Intrathecal catheter granuloma associated with isolated baclofen infusion

Anesthesia and Analgesia

Volumn 102, Issue 3, 2006, Pages 848-852

  Murphy, Paul M ^a   Skouvaklis, Danielle E ^a   Amadeo, Ryan J J ^a   Haberman, Craig ^a   Brazier, David H ^b   Cousins, Michael J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BACLOFEN; BOTULINUM TOXIN A; DANTROLENE; DIAZEPAM; FENTANYL; GABAPENTIN; HYDROMORPHONE; IMIDAZOLE DERIVATIVE; MORPHINE; TIZANIDINE;

ADULT; AMNESIA; ARTICLE; CASE REPORT; CATHETER; CATHETER GRANULOMA; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOMA; HUMAN; NAUSEA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; QUADRIPLEGIA; SEDATION; SIDE EFFECT; SOMNOLENCE; SPASTICITY; SPINAL CORD TRANSSECTION; TITRIMETRY;

EID: 33644537043     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000196523.06573.10     Document Type: Article

References (28)

1. Burchiel KJ, Hsu FPK. Pain and spasticity after spinal cord injury. Spine 2001;26:146-60.
2. Nance P, Schryvers O, Schmidt B, et al. Intrathecal therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 1995;22:22-9.
3. Lazorthes Y, Safferin-Caute B, Verdie JC, et al. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990;72:393-402.
4. Müller H, Zierski J, Dralle D, et al. The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 1987;243:348-52.
5. Coffey JR, Cahill D, Steers W, et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993;78:226-32.
6. Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989;320:1517-21.
7. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions: a pilot study. Clin J Pain 1992;8:338-45.
8. Lobser PG, Akman NM. Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 1996; 12:241-7.
9. Bennett G, Serafini M, Buchiel K, et al. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000;20:S12-36.
10. North RB, Cutchis PN, Epstein JA, et al. Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience. Neurosurgery 1991;29:778-84.
11. Aldrete JA, Vascello LA, Ghaly R, et al. Paraplegia in a patient with an intrathecal catheter and a spinal cord stimulator. Anesthesiology 1994;81:1542-5.
12. Blout JP, Remley KB, Yue SK, et al. Intrathecal granuloma complicating chronic spinal infusion of morphine: report of three cases. J Neurosurg 1996;84:72-6.
13. Bejjani GK, Karim NO, Tzortzidis F. Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature. Surg Neurol 1997;8:288-91.
14. Cabell KL, Taren JA, Sagher OS. Spinal cord compression by catheter granulomas in high dose intrathecal morphine therapy: case report. Neurosurgery 1998;42:1176-81.
15. Anderson SR, Orbegozo M, Racz G, et al. Intrathecal granuloma in patients receiving high-dose intrathecal morphine therapy: a report of two cases. Pain Practice 2001;1:61-7.
16. McMillan MR, Doud T, Nugent W. Catheter-associated masses in patients receiving intrathecal analgesic therapy. Anesth Analg 2003;96:186-90.
17. Coffey RJ, Burchiel K. Inflammatory mass lesions associated with intrathecal drug catheters: report and observations on 41 patients. Neurosurgery 2002;50:78-87.
18. Yaksh TL, Hassenbusch S, Burchiel K, et al. Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. Pain Med 2002;3:300-12.
19. Cooper JF, Harbert JC. Endotoxin as a cause of aseptic meningitis after radionucleotide cisternography. J Nucl Med 1975;16: 809-13.
20. Cooper JF, Thoma LA. Screening extemporaneously compounded intraspinal injections with the bacterial endotoxin test. Am J Health Syst Pharm 2002;59:2426-33.
21. James HE, Tibbs PA. Diverse clinical applications of percutaneous lumboperitoneal shunts. Neurosurgery 1981;8:39-42.
22. McIvor J, Krajbich JI, Hoffman H. Orthopaedic complications of lumboperitoneal shunts. J Pediatr Orthop 1988;8:687-9.
23. Angell M. What's really behind the attack on silicone breast implants? Med Econ 1996;73:131-3,136,139-40.
24. Dahm P, Nitescu P, Appelgren L, et al. Efficacy and technical complications of long-term continuous spinal infusions of opioid and/or bupivacaine in refractory non-malignant pain: a comparison between the epidural and intrathecal approach with externalized or implanted catheters and infusion pumps. Clin J Pain 1998;14:4-16.
25. Jones TF, Feler CA, Simmons BP, et al. Neurological complications including paralysis after a medication error involving implanted intrathecal catheters. Am J Med 2002;112:31-6.
26. Yaksh TL, Horais KA, Tozier NA, et al. Chronically infused intrathecal morphine in dogs. Anesthesiology 2003;99:174-87.
27. Freund M, Adwan M, Kooijman H, et al. Measurement of CSF flow in the spinal canal using MRI with optimized MRI protocol: experimental and clinical studies. Rofo 2001;173: 306-14.
28. Hassenbusch S, Burchiel K, Coffey RJ, et al. Management of intrathecal catheter-tip inflammatory masses: a consensus statement. Pain Med 2002;3:313-23.